Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New Clues For Brain Cancer Treatment Found At The ESRF

05.04.2004


A team of researchers from the University Hospital of Grenoble (CHU – Inserm U647) and the ESRF1 has found a new treatment that improves the survival of rats with high-grade gliomas.



This research was carried out at the ESRF Medical Beamline. It showed that after a year of this treatment, three rats out of 10 were considered cured, whereas without treatment, all would be dead. The results have just been published in the scientific journal Cancer Research. A glioma is one of the most frequent brain tumours in human adults, and it is not curable. Clinical trials on humans are planned for the near future.

Today, the median survival for patients with glioma is less than a year. Around 5 to 10 adults out of 100.000 suffer from this brain tumour. Traditional radiotherapy using hospital X-rays only has a palliative effect because gliomas are some of the most radio-resistant human tumours. Chemotherapy is ineffective most of the time. Several therapeutic techniques have been developed over the last years using animal models, but none has had such successful results as this new treatment with cis-platinum combined with monochromatic synchrotron x-rays. This new technique combines chemotherapy with radiotherapy in such a way that both techniques are effective when associated.


In this study, a drug called Cis-platinum was injected into the brain of rats bearing F98 glioma. The substance entered the DNAs of the tumour and limited the tumoral proliferation. A day later, at the Medical Beamline of the ESRF, the tumour was irradiated with X-rays of a very precise energy (monochromatic) The difference between these X-rays and the conventional X-ray sources used in hospitals is the brilliance: the beam produced by the ESRF synchrotron is a hundred thousand times brighter than the beam produced by a hospital X-ray machine, allowing the beam to be tuned at a convenient wavelength.

This in vivo experiment was preceded by in vitro experiments on cells using the same tumoral model (F98). This tumour is extremely radioresistant and it spreads very quickly. The mean survival time of untreated rats was 28 days. If cis-platinum was injected, they survived up to 39 days. If the rats were irradiated with X-rays at a certain wavelength, it could result in a maximum of 48 days of survival. The combination of both treatments, with a specific radiation dose and a specific X-ray wavelength appeared to be the most efficient treatment tested and offered a mean survival time of around 200 days. This means a 6-fold increase in the life span of treated rats compared to those which didn’t receive any treatment.

The success of the trials has led CHU and ESRF researchers to envisage the elaboration of a protocol in order to use these techniques on humans. “There is a lot of technological development to be carried out, but it is feasible”, explains Doctor François Estève, one of the authors of the paper. “The ESRF Medical Beamline is a unique place in the world where pre-clinical and clinical research in radiotherapy with synchrotron radiation is possible nowadays” says Doctor Alberto Bravin, responsible for the Medical Beamline. Rats and humans don’t have so much physical resemblance, so doctors and physicists still cannot say whether they would have the same outstanding results if humans were treated. But François Estève is convinced that “taking into account the impossibility nowadays of healing this brain tumour, it is really a must to try this method”.

Montserrat Capellas | alfa
Further information:
http://www.esrf.fr

More articles from Life Sciences:

nachricht "Make two out of one" - Division of Artificial Cells
19.02.2020 | Max-Planck-Institut für Kolloid- und Grenzflächenforschung

nachricht Sweet beaks: What Galapagos finches and marine bacteria have in common
19.02.2020 | Max-Planck-Institut für Marine Mikrobiologie

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A step towards controlling spin-dependent petahertz electronics by material defects

The operational speed of semiconductors in various electronic and optoelectronic devices is limited to several gigahertz (a billion oscillations per second). This constrains the upper limit of the operational speed of computing. Now researchers from the Max Planck Institute for the Structure and Dynamics of Matter in Hamburg, Germany, and the Indian Institute of Technology in Bombay have explained how these processes can be sped up through the use of light waves and defected solid materials.

Light waves perform several hundred trillion oscillations per second. Hence, it is natural to envision employing light oscillations to drive the electronic...

Im Focus: Freiburg researcher investigate the origins of surface texture

Most natural and artificial surfaces are rough: metals and even glasses that appear smooth to the naked eye can look like jagged mountain ranges under the microscope. There is currently no uniform theory about the origin of this roughness despite it being observed on all scales, from the atomic to the tectonic. Scientists suspect that the rough surface is formed by irreversible plastic deformation that occurs in many processes of mechanical machining of components such as milling.

Prof. Dr. Lars Pastewka from the Simulation group at the Department of Microsystems Engineering at the University of Freiburg and his team have simulated such...

Im Focus: Skyrmions like it hot: Spin structures are controllable even at high temperatures

Investigation of the temperature dependence of the skyrmion Hall effect reveals further insights into possible new data storage devices

The joint research project of Johannes Gutenberg University Mainz (JGU) and the Massachusetts Institute of Technology (MIT) that had previously demonstrated...

Im Focus: Making the internet more energy efficient through systemic optimization

Researchers at Chalmers University of Technology, Sweden, recently completed a 5-year research project looking at how to make fibre optic communications systems more energy efficient. Among their proposals are smart, error-correcting data chip circuits, which they refined to be 10 times less energy consumptive. The project has yielded several scientific articles, in publications including Nature Communications.

Streaming films and music, scrolling through social media, and using cloud-based storage services are everyday activities now.

Im Focus: New synthesis methods enhance 3D chemical space for drug discovery

After helping develop a new approach for organic synthesis -- carbon-hydrogen functionalization -- scientists at Emory University are now showing how this approach may apply to drug discovery. Nature Catalysis published their most recent work -- a streamlined process for making a three-dimensional scaffold of keen interest to the pharmaceutical industry.

"Our tools open up whole new chemical space for potential drug targets," says Huw Davies, Emory professor of organic chemistry and senior author of the paper.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

70th Lindau Nobel Laureate Meeting: Around 70 Laureates set to meet with young scientists from approx. 100 countries

12.02.2020 | Event News

11th Advanced Battery Power Conference, March 24-25, 2020 in Münster/Germany

16.01.2020 | Event News

Laser Colloquium Hydrogen LKH2: fast and reliable fuel cell manufacturing

15.01.2020 | Event News

 
Latest News

"Make two out of one" - Division of Artificial Cells

19.02.2020 | Life Sciences

High-Performance Computing Center of the University of Stuttgart Receives new Supercomuter "Hawk"

19.02.2020 | Information Technology

A step towards controlling spin-dependent petahertz electronics by material defects

19.02.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>